⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Legend Biotech and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Legend Biotech
↗Somerset, USA
Legend Biotech is a global, commercial-stage biopharmaceutical company focused on the discovery and development of novel cell therapies for oncology and other indications. Founded in 2014, the company specializes in chimeric antigen receptor T-cell (CAR-T) therapies, including its flagship product, CARVYKTI (ciltacabtagene autoleucel), which is approved for the treatment of multiple myeloma.
The company operates with a global footprint, with headquarters in Somerset, New Jersey, and additional R&D and manufacturing sites in China and Europe. Legend Biotech utilizes an end-to-end cell therapy model, covering discovery through commercialization, and maintains a significant strategic partnership with Janssen Biotech (a Johnson & Johnson company) for the development and commercialization of its lead assets.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B+
Founded:2014
Ownership:public
Status:operating
FUNDING
Total Raised:$150M
STOCK
Exchange:NASDAQ
Ticker:LEGN
Market Cap:$4.66B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Cell therapy, CAR-T, CAR-NK, CAR-γδ T
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:Janssen Biotech (Johnson & Johnson): Global collaboration for the co-development and commercialization of cilta-cel.
COMPETITION
Position:Leader
Competitors:Jazz Pharmaceuticals, Moderna, Sana Biotechnology
LEADERSHIP
Key Executives:
Frank Fan - Founder
Scientific Founders:Frank Fan
LINKS
Website:legendbiotech.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Legend Biotech. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.